Skip to content

Survey on the proportion of alcohol-dependent patients receiving outpatient treatment in the early stages of treatment and the actual status of treatment using claims data in Japan

Survey on the proportion of alcohol-dependent patients receiving outpatient treatment in the early stages of treatment and the actual status of treatment using claims data in Japan - Survey on the proportion of alcohol-dependent patients receiving outpatient treatment in the early stages of treatment and the actual status of treatment using claims data in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000055158
Enrollment
2101
Registered
2024-12-01
Start date
2023-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Dependence

Interventions

None listed

Sponsors

Otsuka Pharmaceutical Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with "ICD-10 Code: F10.2 Mental and behavioral disorders due to use of alcohol Dependence syndrome" during the enrollment period.

Exclusion criteria

Exclusion criteria: Patients under 20 years old Patients who were diagnosed with "ICD-10 Code: F10.2 Mental and behavioral disorders due to use of alcohol Dependence syndrome" within one year prior to their first diagnosis of alcohol dependence during the enrollment period Patients who were only suspected of having "ICD-10 Code: F10.2 Mental and behavioral disorders due to use of alcohol Dependence syndrome" within one year after their first diagnosis of alcohol dependence during the enrollment period Patients whose health insurance enrollment period was less than one year prior to their first diagnosis of alcohol dependence during the enrollment period Patients whose health insurance enrollment period was less than one year after their first diagnosis of alcohol dependence during the enrollment period

Design outcomes

Primary

MeasureTime frame
Outpatient treatment continuation rate

Secondary

MeasureTime frame
Prevalence of comorbidities before and after the initial diagnosis of alcohol dependence Prescription rate of medications in the year before and after the initial diagnosis of alcohol dependence (medications for alcohol dependence, nicotine dependence, anti-anxiety drugs, sleep and sedative drugs, painkillers, antidepressants, schizophrenia drugs, mood stabilizers, anti-epileptics, etc.) Implementation rate of psychosocial therapy in the year before and after the initial diagnosis of alcohol dependence, etc.

Countries

Japan

Contacts

Public ContactYoshitsugu Kojima

Otsuka Pharmaceutical Co.,Ltd. Medical Affairs

kojimayo@otsuka.jp03-6717-1400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026